Clinical Trial Update: Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of anastrozole and fulvestrant in ER-positive, HER2-negative operable breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED